Systematic ReviewOpen AccessOpen Access license
Pembrolizumab plus chemotherapy for first-line treatment of metastatic nonsquamous non-small-cell lung cancer: a network meta-analysis
Published Online:4 Feb 2019https://doi.org/10.2217/imt-2018-0193
- Cited By
- 22 March 2024 | Advanced Science, Vol. 12
- 19 July 2023 | Immunotherapy, Vol. 15, No. 13
- 6 July 2023 | Frontiers in Oncology, Vol. 13
- 7 February 2023 | Immunotherapy, Vol. 15, No. 4
- 7 February 2023 | Frontiers in Oncology, Vol. 13
- 17 October 2022 | Strahlentherapie und Onkologie, Vol. 199, No. 2
- 12 March 2022 | Journal of Hematology & Oncology, Vol. 15, No. 1
- 24 February 2022 | Communications Biology, Vol. 5, No. 1
- 26 October 2022 | Frontiers in Immunology, Vol. 13
- 15 September 2022 | Frontiers in Immunology, Vol. 13
- 21 March 2022 | Future Oncology, Vol. 18, No. 15
- 20 April 2022 | Cancers, Vol. 14, No. 9
- 19 May 2022 | Biomedicines, Vol. 10, No. 5
- 25 January 2022 | Immunotherapy, Vol. 14, No. 5
- Cancer Cell, Vol. 40, No. 2
- Journal of Controlled Release, Vol. 341
- 28 April 2021 | Scientific Reports, Vol. 11, No. 1
- 12 September 2021 | Histopathology, Vol. 79, No. 6
- 29 November 2021 | Science Progress, Vol. 104, No. 4
- 15 September 2021 | Frontiers in Oncology, Vol. 11
- Clinical Genitourinary Cancer, Vol. 19, No. 4
- Lung Cancer, Vol. 155
- 5 January 2021 | Frontiers in Oncology, Vol. 10
- 9 July 2020 | BMC Cancer, Vol. 20, No. 1
- 4 December 2020 | Cancers, Vol. 12, No. 12
- 14 March 2020 | Drug Delivery and Translational Research, Vol. 10, No. 5
- JAMA Oncology, Vol. 6, No. 6
- 20 May 2020 | Drugs, Vol. 80, No. 9
- 1 April 2020 | Acta Otorhinolaryngologica Italica, Vol. 40, No. SUPPL. 1
- 24 March 2020 | Frontiers in Medicine, Vol. 7
- 12 March 2020 | Frontiers in Immunology, Vol. 11
- 20 December 2019 | Biomolecules, Vol. 10, No. 1
- Cancer Research, Statistics, and Treatment, Vol. 3, No. 1
- 14 November 2019 | Targeted Oncology, Vol. 14, No. 6
- 14 November 2019 | Expert Opinion on Therapeutic Targets, Vol. 23, No. 11
- 19 September 2019 | Expert Review of Respiratory Medicine, Vol. 13, No. 11
- 24 October 2019 | Frontiers in Pharmacology, Vol. 10
- Lung Cancer, Vol. 134
- 9 December 2019 | Kompass Pneumologie, Vol. 7, No. 6
Supplemental Materials
Downloaded 13,901 times
Received 1 December 2018
Accepted 11 January 2019
Published online 4 February 2019
Published in print April 2019
© 2019 Andrew M Frederickson
The research was funded by Merck & Co., Inc. Authors R Insinga, A Arunachalam and TA Burke are employees of Merck & Co., Inc. AM Frederickson, S Arndorfer, I Zhang and M Lorenzi are employees of Precision Xtract, a consultancy contracted by Merck & Co., Inc. to conduct research. GR Simon is a paid consultant to Merck & Co., Inc. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.
This work is licensed under the Attribution-NonCommercial-NoDerivatives 4.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/
